Skip to main content
Top
Published in: Esophagus 1/2017

01-01-2017 | Original Article

Standard values of 24-h multichannel intraluminal impedance–pH monitoring for the Japanese

Authors: Fumiaki Yano, Nobuo Omura, Kazuto Tsuboi, Masato Hoshino, Se Ryung Yamamoto, Shunsuke Akimoto, Takahiro Masuda, Norio Mitsumori, Hideyuki Kashiwagi, Katsuhiko Yanaga

Published in: Esophagus | Issue 1/2017

Login to get access

Abstract

Background

Combined multichannel intraluminal impedance and pH monitoring (MII–pH) is the gold standard for diagnosing gastroesophageal reflux (GER), but there are no concrete data for a Japanese population. The aim of this study is to determine the standard values of MII–pH for a Japanese population.

Methods

Twenty healthy Japanese volunteers without symptoms of GER were recruited through the homepage of the Department of Surgery at The Jikei University School of Medicine. Their mean age was 29.0 ± 3.0 years (range 24–36) and three of the volunteers were women (15 % of the total number of volunteers). The volunteers underwent MII–pH measurements at 6 sites. These sites were centered at 3, 5, 7, 9, 15, and 17 cm higher than the lower esophageal sphincter (LES) and a pH-monitoring device was placed 5 cm above the upper border of the LES. GER events were detected and divided into acid or non-acid reflux by pH and liquid acid or liquid non-acid reflux by impedance.

Results

The normal values of MII–pH for the Japanese population were as follows: a pH below 4 holding time of less than 2.5 %, less than 2.1 total number of reflux events longer than 5 min, duration of the longest reflux event less than 12.7, and DeMeester Score less than 11.0. The total number of liquid reflux events was less than 80. The total number of liquid acid reflux events and liquid non-acid reflux events was less than 49 and 58, respectively.

Conclusions

We provided the standard values of MII–pH for a Japanese population.
Literature
1.
go back to reference Heard R, Castell J, Castell DO, et al. Characterization of patients with low baseline impedance on multichannel intraluminal impedance–pH reflux testing. J Clin Gastroenterol. 2012;46:e55–7.CrossRefPubMed Heard R, Castell J, Castell DO, et al. Characterization of patients with low baseline impedance on multichannel intraluminal impedance–pH reflux testing. J Clin Gastroenterol. 2012;46:e55–7.CrossRefPubMed
2.
go back to reference Tutuian R, Castell DO. Review article: complete gastro-oesophageal reflux monitoring—combined pH and impedance. Aliment Pharmacol Ther. 2006;24(Suppl 2):27–37.CrossRefPubMed Tutuian R, Castell DO. Review article: complete gastro-oesophageal reflux monitoring—combined pH and impedance. Aliment Pharmacol Ther. 2006;24(Suppl 2):27–37.CrossRefPubMed
3.
go back to reference Savarino E, Zentilin P, Tutuian R, et al. Impedance–pH reflux patterns can differentiate non-erosive reflux disease from functional heartburn patients. J Gastroenterol. 2012;47:159–68.CrossRefPubMed Savarino E, Zentilin P, Tutuian R, et al. Impedance–pH reflux patterns can differentiate non-erosive reflux disease from functional heartburn patients. J Gastroenterol. 2012;47:159–68.CrossRefPubMed
4.
go back to reference Johnson LF, Demeester TR. Twenty-four-hour pH monitoring of the distal esophagus. A quantitative measure of gastroesophageal reflux. Am J Gastroenterol. 1974;62:325–32.PubMed Johnson LF, Demeester TR. Twenty-four-hour pH monitoring of the distal esophagus. A quantitative measure of gastroesophageal reflux. Am J Gastroenterol. 1974;62:325–32.PubMed
5.
go back to reference Tutuian R, Vela MF, Shay SS, et al. Multichannel intraluminal impedance in esophageal function testing and gastroesophageal reflux monitoring. J Clin Gastroenterol. 2003;37:206–15.CrossRefPubMed Tutuian R, Vela MF, Shay SS, et al. Multichannel intraluminal impedance in esophageal function testing and gastroesophageal reflux monitoring. J Clin Gastroenterol. 2003;37:206–15.CrossRefPubMed
6.
go back to reference Petersen H, Schrumpf E, Myren J. Fasting serum gastrin and basal gastric acid secretion. Scand J Gastroenterol. 1975;10:721–4.PubMed Petersen H, Schrumpf E, Myren J. Fasting serum gastrin and basal gastric acid secretion. Scand J Gastroenterol. 1975;10:721–4.PubMed
7.
go back to reference Wildi SM, Tutuian R, Castell DO. The influence of rapid food intake on postprandial reflux: studies in healthy volunteers. Am J Gastroenterol. 2004;99:1645–51.CrossRefPubMed Wildi SM, Tutuian R, Castell DO. The influence of rapid food intake on postprandial reflux: studies in healthy volunteers. Am J Gastroenterol. 2004;99:1645–51.CrossRefPubMed
8.
go back to reference Carlsson R, Dent J, Bolling-Sternevald E, et al. The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease. Scand J Gastroenterol. 1998;33:1023–9.CrossRefPubMed Carlsson R, Dent J, Bolling-Sternevald E, et al. The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease. Scand J Gastroenterol. 1998;33:1023–9.CrossRefPubMed
9.
go back to reference Kusano M, Shimoyama Y, Sugimoto S, et al. Development and evaluation of FSSG: frequency scale for the symptoms of GERD. J Gastroenterol. 2004;39:888–91.CrossRefPubMed Kusano M, Shimoyama Y, Sugimoto S, et al. Development and evaluation of FSSG: frequency scale for the symptoms of GERD. J Gastroenterol. 2004;39:888–91.CrossRefPubMed
10.
go back to reference Tutuian R, Mainie I, Agrawal A, et al. Nonacid reflux in patients with chronic cough on acid-suppressive therapy. Chest. 2006;130:386–91.CrossRefPubMed Tutuian R, Mainie I, Agrawal A, et al. Nonacid reflux in patients with chronic cough on acid-suppressive therapy. Chest. 2006;130:386–91.CrossRefPubMed
11.
go back to reference Savarino E, Zentilin P, Tutuian R, et al. The role of nonacid reflux in NERD: lessons learned from impedance–pH monitoring in 150 patients off therapy. Am J Gastroenterol. 2008;103:2685–93.CrossRefPubMed Savarino E, Zentilin P, Tutuian R, et al. The role of nonacid reflux in NERD: lessons learned from impedance–pH monitoring in 150 patients off therapy. Am J Gastroenterol. 2008;103:2685–93.CrossRefPubMed
12.
go back to reference Shay S, Tutuian R, Sifrim D, et al. Twenty-four hour ambulatory simultaneous impedance and pH monitoring: a multicenter report of normal values from 60 healthy volunteers. Am J Gastroenterol. 2004;99:1037–43.CrossRefPubMed Shay S, Tutuian R, Sifrim D, et al. Twenty-four hour ambulatory simultaneous impedance and pH monitoring: a multicenter report of normal values from 60 healthy volunteers. Am J Gastroenterol. 2004;99:1037–43.CrossRefPubMed
13.
go back to reference Tamhankar AP, Peters JH, Portale G, et al. Omeprazole does not reduce gastroesophageal reflux: new insights using multichannel intraluminal impedance technology. J Gastrointest Surg. 2004;8:890–7 (discussion 897–8).CrossRefPubMed Tamhankar AP, Peters JH, Portale G, et al. Omeprazole does not reduce gastroesophageal reflux: new insights using multichannel intraluminal impedance technology. J Gastrointest Surg. 2004;8:890–7 (discussion 897–8).CrossRefPubMed
14.
go back to reference Xiao YL, Lin JK, Cheung TK, et al. Normal values of 24-hour combined esophageal multichannel intraluminal impedance and pH monitoring in the Chinese population. Digestion. 2009;79:109–14.CrossRefPubMed Xiao YL, Lin JK, Cheung TK, et al. Normal values of 24-hour combined esophageal multichannel intraluminal impedance and pH monitoring in the Chinese population. Digestion. 2009;79:109–14.CrossRefPubMed
15.
go back to reference Mousa H, Machado R, Orsi M, et al. Combined multichannel intraluminal impedance–pH (MII–pH): multicenter report of normal values from 117 children. Curr Gastroenterol Rep. 2014;16:400.CrossRefPubMed Mousa H, Machado R, Orsi M, et al. Combined multichannel intraluminal impedance–pH (MII–pH): multicenter report of normal values from 117 children. Curr Gastroenterol Rep. 2014;16:400.CrossRefPubMed
16.
go back to reference Wise JL, Murray JA. Utilising multichannel intraluminal impedance for diagnosing GERD: a review. Dis Esophagus. 2007;20:83–8.CrossRefPubMed Wise JL, Murray JA. Utilising multichannel intraluminal impedance for diagnosing GERD: a review. Dis Esophagus. 2007;20:83–8.CrossRefPubMed
17.
go back to reference Katelaris PH, Seow F, Lin BP, et al. Effect of age, Helicobacter pylori infection, and gastritis with atrophy on serum gastrin and gastric acid secretion in healthy men. Gut. 1993;34:1032–7.CrossRefPubMedPubMedCentral Katelaris PH, Seow F, Lin BP, et al. Effect of age, Helicobacter pylori infection, and gastritis with atrophy on serum gastrin and gastric acid secretion in healthy men. Gut. 1993;34:1032–7.CrossRefPubMedPubMedCentral
18.
go back to reference Sonnenberg A. Effects of environment and lifestyle on gastroesophageal reflux disease. Dig Dis. 2011;29:229–34.CrossRefPubMed Sonnenberg A. Effects of environment and lifestyle on gastroesophageal reflux disease. Dig Dis. 2011;29:229–34.CrossRefPubMed
Metadata
Title
Standard values of 24-h multichannel intraluminal impedance–pH monitoring for the Japanese
Authors
Fumiaki Yano
Nobuo Omura
Kazuto Tsuboi
Masato Hoshino
Se Ryung Yamamoto
Shunsuke Akimoto
Takahiro Masuda
Norio Mitsumori
Hideyuki Kashiwagi
Katsuhiko Yanaga
Publication date
01-01-2017
Publisher
Springer Japan
Published in
Esophagus / Issue 1/2017
Print ISSN: 1612-9059
Electronic ISSN: 1612-9067
DOI
https://doi.org/10.1007/s10388-016-0549-1

Other articles of this Issue 1/2017

Esophagus 1/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.